Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine with Pregabalin and Duloxetine for Postherpetic Neuralgia
NCT06896994Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Apr 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of esketamine in postherpetic neuralgia (PHN) (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Mean of Daily Pain Scores at 1 week. Started Apr 2025; status: recruiting.
02
Drugs
esketamine
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT06896994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06896994.